SlideShare a Scribd company logo
Effects of Acamprosate, Naltrexone and CaCl2 on cognitive flexibility and synaptic function in mice following
chronic-intermittent ethanol (CIE) exposure or operant alcohol self-administration
Aarron Phensy, Grishma Pradhan, Rohith Kandunuri, Hannah Fang, Amogh Singhal, Sven Kroener
School of Behavioral and Brain Sciences, The University of Texas at Dallas
SUMMARY
Operant - Electrophysiology
548.21
CIE -
Attentional
Set-Shifting –
Digging Task
CIE –
Attentional
Set-Shifting
Visual Cue-Based
CIE - Novel Object
Recognition
Operant - Attentional Set-Shifting
Animals required significantly more
trials to meet criterion for an
attentional set-shifting task following
CIE treatment. Acamprosate, CaCl
and Naltrexone were all successful in
recovering this deficit
CIE animals show deficits
during IDR2 as well as EDR,
suggesting additional
cognitive deficits.
These changes were
prevented by both
Acamprosate and CaCl
treatment
CIE has no effect on
normal patterns of
social interaction
CIE treatment resulted in a deficit in novel
object recognition which was recovered with
treatment of Acamprosate, CaCl and
Naltrexone
Animals who went through operant
drinking showed deficits in their
ability to shift their attention to a
visual cue during an attentional set-
shifting task. Treatment with
acamprosate prevented this deficit.
Following operant drinking and 3
or 4 days of withdrawal, animals
show increased in NMDA:AMPA
ratios in layer 5 pyramidal cells.
This is reversed by acamprosate
The frequency or amplitude o spontaneous
EPSCs is not affected by moderate levels of
alcohol drinkingCIE – Social Interaction
Alcohol addiction is a downward spiral in which loss of cognitive control over decision making can
result in repeated abuse. Mice that have been given chronic-intermittent ethanol (CIE) exposure
exhibit a decrease in performance in PFC-dependent tasks such as attentional set-shifting tasks.
Acamprosate is one of the leading drugs prescribed in order to maintain abstinence of alcohol and
can prevent these cognitive deficits in mice. Here we examine if CaCl, a suspect active moiety in
Acamprosate as well as the opioid-antagonist Naltrexone can also prevent cognitive deficits in
CIE exposed mice.
Evidence suggests that loss of cognitive control is due to maladaptive synaptic plasticity in the
prefrontal cortex. We have previously shown that following chronic-intermittent ethanol (CIE)
treatment, mice exhibit increased NMDA function in layer 5 pyramidal neurons as well as
increased excitability. However treatment with Acamprosate did not correct this change.
Importantly, alcohol dependence is usually a learned behavior. Here we examine cognitive as well
as synaptic changes following an operant alcohol exposure paradigm as well as the effects of
Acamprosate in this paradigm.
 C57 mice began alcohol exposure on one of the two timelines described below starting at PND 80
 Mice were food restricted to 85% of their baseline weight for the attentional set-shifting task
 During the treatment period mice were given injections of either saline, 200mg/kg Acamprosate, 147mg/kg
CaCl, or 10mg/kg Naltrexone twice a day for three days
 Following treatment, mice went through a battery of behavioral tests or were sacrificed for
electrophysiological recordings
 Whole cell patch clamp recordings in layer 5 pyramidal cells of the mPFC layer 2/3 were performed in the
presence of picrotoxin to study alterations in glutamatergic synaptic transmission
METHODS
INTRODUCTION
Chronic-Intermittent Ethanol (CIE) Timeline
Operant Drinking Timeline
• Chronic-intermittent ethanol exposure results in cognitive deficits in mice as revealed through
two different attentional set-shifting tasks, as well as a novel object recognition task.
Performance in all three tasks was able to be restored if either Acamprosate, CaCl or Naltrexone
were given during withdrawal.
• CIE did not impact the normal pattern of social interactions in mice
• Operant alcohol drinking also resulted in cognitive deficits as measured via the attentional set
shifting (shift-to-cue) task. This deficit was ameliorated with Acamprosate treatment.
• Operant alcohol exposure lead to an increase in NMDA function which, unlike previously
demonstrated shifts induced by CIE (Hu et al., 20015), was reversed by treatment with
Acamprosate.

More Related Content

Similar to SFN2016_Poster_Final

Screening models for Anti-Amnesic activity evaluation: A Review
Screening models for Anti-Amnesic activity evaluation: A ReviewScreening models for Anti-Amnesic activity evaluation: A Review
Screening models for Anti-Amnesic activity evaluation: A Review
pharmaindexing
 
CPC PENN Stress Meeting 2012_1
CPC PENN Stress Meeting 2012_1CPC PENN Stress Meeting 2012_1
CPC PENN Stress Meeting 2012_1Stacia Lewandowski
 
MetabolicAcidosisinA.pdf
MetabolicAcidosisinA.pdfMetabolicAcidosisinA.pdf
MetabolicAcidosisinA.pdf
Hosneara18
 
Alznovelarghyafinal
AlznovelarghyafinalAlznovelarghyafinal
Alznovelarghyafinal
Arghya Chowdhury
 
NIH Poster Brian A. Smith
NIH Poster Brian A. SmithNIH Poster Brian A. Smith
NIH Poster Brian A. SmithBrian A. Smith
 
Study of anticonvulsant activity of quinidine in albino rats using pentylenet...
Study of anticonvulsant activity of quinidine in albino rats using pentylenet...Study of anticonvulsant activity of quinidine in albino rats using pentylenet...
Study of anticonvulsant activity of quinidine in albino rats using pentylenet...
iosrjce
 
Participation of the gabaergic system on the glutamate
Participation of the gabaergic system on the glutamateParticipation of the gabaergic system on the glutamate
Participation of the gabaergic system on the glutamate
ankit
 
Anti psychotic screening methods
Anti psychotic screening methodsAnti psychotic screening methods
Anti psychotic screening methods
SurpriseSurendhar
 
Ketamine as a neuroapoptotic agent
Ketamine as a neuroapoptotic agentKetamine as a neuroapoptotic agent
Ketamine as a neuroapoptotic agent
aparna jayara
 
Alcoholic neuropathy 2012
Alcoholic neuropathy 2012Alcoholic neuropathy 2012
Alcoholic neuropathy 2012
Electrodx Inr
 
Presentation on Epilepsy and Its Animal Models
Presentation on Epilepsy and Its Animal ModelsPresentation on Epilepsy and Its Animal Models
Presentation on Epilepsy and Its Animal Models
Gagandeep Jaiswal
 
The Effect of Curcumin on AMPA Receptors Pharmacokinetics
The Effect of Curcumin on AMPA Receptors PharmacokineticsThe Effect of Curcumin on AMPA Receptors Pharmacokinetics
The Effect of Curcumin on AMPA Receptors Pharmacokinetics
Hasan Arafat
 
Inestrosa idn 2011
Inestrosa idn 2011Inestrosa idn 2011
Inestrosa idn 2011Jorge Parodi
 
Inestrosa idn 2011
Inestrosa idn 2011Inestrosa idn 2011
Inestrosa idn 2011Jorge Parodi
 

Similar to SFN2016_Poster_Final (20)

Screening models for Anti-Amnesic activity evaluation: A Review
Screening models for Anti-Amnesic activity evaluation: A ReviewScreening models for Anti-Amnesic activity evaluation: A Review
Screening models for Anti-Amnesic activity evaluation: A Review
 
SandhuPoster2011
SandhuPoster2011SandhuPoster2011
SandhuPoster2011
 
CPC PENN Stress Meeting 2012_1
CPC PENN Stress Meeting 2012_1CPC PENN Stress Meeting 2012_1
CPC PENN Stress Meeting 2012_1
 
MetabolicAcidosisinA.pdf
MetabolicAcidosisinA.pdfMetabolicAcidosisinA.pdf
MetabolicAcidosisinA.pdf
 
Memory2
Memory2Memory2
Memory2
 
Caryne Stacia Neuropharm
Caryne Stacia NeuropharmCaryne Stacia Neuropharm
Caryne Stacia Neuropharm
 
i29.full
i29.fulli29.full
i29.full
 
Alznovelarghyafinal
AlznovelarghyafinalAlznovelarghyafinal
Alznovelarghyafinal
 
NIH Poster Brian A. Smith
NIH Poster Brian A. SmithNIH Poster Brian A. Smith
NIH Poster Brian A. Smith
 
2014 BDSRA Davidson LINCL
2014 BDSRA Davidson LINCL2014 BDSRA Davidson LINCL
2014 BDSRA Davidson LINCL
 
Screening models of alzheimer disease
Screening models of alzheimer diseaseScreening models of alzheimer disease
Screening models of alzheimer disease
 
Study of anticonvulsant activity of quinidine in albino rats using pentylenet...
Study of anticonvulsant activity of quinidine in albino rats using pentylenet...Study of anticonvulsant activity of quinidine in albino rats using pentylenet...
Study of anticonvulsant activity of quinidine in albino rats using pentylenet...
 
Participation of the gabaergic system on the glutamate
Participation of the gabaergic system on the glutamateParticipation of the gabaergic system on the glutamate
Participation of the gabaergic system on the glutamate
 
Anti psychotic screening methods
Anti psychotic screening methodsAnti psychotic screening methods
Anti psychotic screening methods
 
Ketamine as a neuroapoptotic agent
Ketamine as a neuroapoptotic agentKetamine as a neuroapoptotic agent
Ketamine as a neuroapoptotic agent
 
Alcoholic neuropathy 2012
Alcoholic neuropathy 2012Alcoholic neuropathy 2012
Alcoholic neuropathy 2012
 
Presentation on Epilepsy and Its Animal Models
Presentation on Epilepsy and Its Animal ModelsPresentation on Epilepsy and Its Animal Models
Presentation on Epilepsy and Its Animal Models
 
The Effect of Curcumin on AMPA Receptors Pharmacokinetics
The Effect of Curcumin on AMPA Receptors PharmacokineticsThe Effect of Curcumin on AMPA Receptors Pharmacokinetics
The Effect of Curcumin on AMPA Receptors Pharmacokinetics
 
Inestrosa idn 2011
Inestrosa idn 2011Inestrosa idn 2011
Inestrosa idn 2011
 
Inestrosa idn 2011
Inestrosa idn 2011Inestrosa idn 2011
Inestrosa idn 2011
 

SFN2016_Poster_Final

  • 1. Effects of Acamprosate, Naltrexone and CaCl2 on cognitive flexibility and synaptic function in mice following chronic-intermittent ethanol (CIE) exposure or operant alcohol self-administration Aarron Phensy, Grishma Pradhan, Rohith Kandunuri, Hannah Fang, Amogh Singhal, Sven Kroener School of Behavioral and Brain Sciences, The University of Texas at Dallas SUMMARY Operant - Electrophysiology 548.21 CIE - Attentional Set-Shifting – Digging Task CIE – Attentional Set-Shifting Visual Cue-Based CIE - Novel Object Recognition Operant - Attentional Set-Shifting Animals required significantly more trials to meet criterion for an attentional set-shifting task following CIE treatment. Acamprosate, CaCl and Naltrexone were all successful in recovering this deficit CIE animals show deficits during IDR2 as well as EDR, suggesting additional cognitive deficits. These changes were prevented by both Acamprosate and CaCl treatment CIE has no effect on normal patterns of social interaction CIE treatment resulted in a deficit in novel object recognition which was recovered with treatment of Acamprosate, CaCl and Naltrexone Animals who went through operant drinking showed deficits in their ability to shift their attention to a visual cue during an attentional set- shifting task. Treatment with acamprosate prevented this deficit. Following operant drinking and 3 or 4 days of withdrawal, animals show increased in NMDA:AMPA ratios in layer 5 pyramidal cells. This is reversed by acamprosate The frequency or amplitude o spontaneous EPSCs is not affected by moderate levels of alcohol drinkingCIE – Social Interaction Alcohol addiction is a downward spiral in which loss of cognitive control over decision making can result in repeated abuse. Mice that have been given chronic-intermittent ethanol (CIE) exposure exhibit a decrease in performance in PFC-dependent tasks such as attentional set-shifting tasks. Acamprosate is one of the leading drugs prescribed in order to maintain abstinence of alcohol and can prevent these cognitive deficits in mice. Here we examine if CaCl, a suspect active moiety in Acamprosate as well as the opioid-antagonist Naltrexone can also prevent cognitive deficits in CIE exposed mice. Evidence suggests that loss of cognitive control is due to maladaptive synaptic plasticity in the prefrontal cortex. We have previously shown that following chronic-intermittent ethanol (CIE) treatment, mice exhibit increased NMDA function in layer 5 pyramidal neurons as well as increased excitability. However treatment with Acamprosate did not correct this change. Importantly, alcohol dependence is usually a learned behavior. Here we examine cognitive as well as synaptic changes following an operant alcohol exposure paradigm as well as the effects of Acamprosate in this paradigm.  C57 mice began alcohol exposure on one of the two timelines described below starting at PND 80  Mice were food restricted to 85% of their baseline weight for the attentional set-shifting task  During the treatment period mice were given injections of either saline, 200mg/kg Acamprosate, 147mg/kg CaCl, or 10mg/kg Naltrexone twice a day for three days  Following treatment, mice went through a battery of behavioral tests or were sacrificed for electrophysiological recordings  Whole cell patch clamp recordings in layer 5 pyramidal cells of the mPFC layer 2/3 were performed in the presence of picrotoxin to study alterations in glutamatergic synaptic transmission METHODS INTRODUCTION Chronic-Intermittent Ethanol (CIE) Timeline Operant Drinking Timeline • Chronic-intermittent ethanol exposure results in cognitive deficits in mice as revealed through two different attentional set-shifting tasks, as well as a novel object recognition task. Performance in all three tasks was able to be restored if either Acamprosate, CaCl or Naltrexone were given during withdrawal. • CIE did not impact the normal pattern of social interactions in mice • Operant alcohol drinking also resulted in cognitive deficits as measured via the attentional set shifting (shift-to-cue) task. This deficit was ameliorated with Acamprosate treatment. • Operant alcohol exposure lead to an increase in NMDA function which, unlike previously demonstrated shifts induced by CIE (Hu et al., 20015), was reversed by treatment with Acamprosate.